Company Registration 5 November 2026
GSK India Analyst Meet Highlights SEBI Compliance and ISO Certification
The 2026 analyst meeting for GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) in India focused on the company's strict adherence to SEBI Listing Obligations and Disclosure norms, while also noting that the event organizer, Kalkine Consultancy India Private Limited, is ISO 27001:2022 certified, underscoring robust data security and governance practices for shareholders and regulators alike.
The analyst meeting for GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) in 2026 covered recent compliance steps and security standards.
- Confirmed adherence to SEBI Listing Obligations and Disclosure requirements.
- Noted that Kalkine Consultancy India Pvt Ltd, the host, holds ISO 27001:2022 certification.
Investors were reassured about strong governance and data protection measures. For full details see the Kalkine article.
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.